Desferal
Showing 1 - 23 of 23
Aneurysmal Subarachnoid Hemorrhage Trial in Ann Arbor, Beijing (Deferoxamine, Placebo)
Recruiting
- Aneurysmal Subarachnoid Hemorrhage
- Deferoxamine
- Placebo
-
Ann Arbor, Michigan
- +1 more
Mar 28, 2022
Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))
Completed
- Thalassemia
- Iron Overload
- Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
-
Oakland, CaliforniaCHRCO
Jul 20, 2021
COVID-19 Trial in Kermanshah (Deferoxamine)
Unknown status
- COVID-19
-
Kermanshah, Iran, Islamic Republic ofRegenerative Medicine Research Center, Kermanshah University of
Apr 30, 2020
COVID19, Intensive Care Unit Trial in Ariana (Tocilizumab Injection, Deferoxamine)
Unknown status
- COVID19
- Intensive Care Unit
- Tocilizumab Injection
- Deferoxamine
-
Ariana, TunisiaEshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Aria
Aug 26, 2020
Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)
Completed
- Myelodysplastic Syndrome
- Iron Overload
-
Birmingham, Alabama
- +47 more
Jul 21, 2021
Transfusion-dependent ß-thalassemia Patients, Cardiac Iron Overload Trial in Athens, Patras (Deferasirox, Deferoxamine (DFO))
Terminated
- Transfusion-dependent β-thalassemia Patients
- Cardiac Iron Overload
- Deferasirox
- Deferoxamine (DFO)
-
Athens, GR, Greece
- +3 more
Oct 21, 2019
Transfusion-dependent Hemachromatosis, Thalassemia Major, Sickle Cell Disease Trial in Boston (Deferoxamine, Deferasirox, HIDA)
Completed
- Transfusion-dependent Hemachromatosis
- +2 more
- Deferoxamine
- +2 more
-
Boston, MassachusettsChildren's Hospital Boston
Jun 14, 2019
Deferoxamine for the Treatment of Hemochromatosis
Completed
- Diabetes Mellitus
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019
Beta-thalassemia, Iron Overload Trial in Los Angeles, Oakland, Chicago (Deferasirox)
Completed
- Beta-thalassemia
- Iron Overload
-
Los Angeles, California
- +2 more
Jun 8, 2021
Intracranial Aneurysm, Subarachnoid Hemorrhage Trial in Nijmegen, Groningen (Deferoxamine, )
Unknown status
- Intracranial Aneurysm
- Subarachnoid Hemorrhage
- Deferoxamine
- placebo
-
Nijmegen, Gelderland, Netherlands
- +1 more
Sep 26, 2017
Thalassemia Trial in Karachi (Standard Chelation, Amlodipine)
Completed
- Thalassemia
- Standard Chelation
- Amlodipine
-
Karachi, Sindh, PakistanAga Khan University Hospital
Jun 28, 2017
Beta-thalassemia Major Complicated With Diabetes Trial in Cairo (Zinc)
Completed
- Beta-thalassemia Major Complicated With Diabetes
-
Cairo, EgyptNancy Elbarbary
Feb 21, 2019
Subarachnoid Hemorrhage Trial in Boston (desferrioxamine (DFO), )
Terminated
- Subarachnoid Hemorrhage
- desferrioxamine (DFO)
- placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 17, 2015
High-Tc Susceptometer to Monitor Transfusional Iron Overload
Completed
- Transfusional Iron Overload
- +4 more
- Hepatic biomagnetic susceptibility measurement
-
New York, New YorkColumbia University Medical Center
Sep 20, 2016
Stroke, Problem of Aging Trial in Boston (desferrioxamine)
Completed
- Stroke
- Problem of Aging
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 26, 2015
Beta-thalassemia, Serum Ferritin, Iron Chelation Therapy Trial in Cairo (desferal, ferriprox, blood transfusion)
Unknown status
- Beta-thalassemia
- +2 more
- desferal, ferriprox, blood transfusion
-
Cairo, EgyptPediatric Hematology clinic, Ain Shams University
Jan 13, 2015
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Boston (deferoxamine)
Terminated
- Acute Myeloid Leukemia
- +2 more
-
Boston, Massachusetts
- +1 more
Apr 5, 2013
Beta-thalassemia Major, Sickle Cell Disease, Iron Hemosiderosis Trial in Cairo (DFP (ferriprox) and deferasirox (ICL 670), DFP,
Unknown status
- Beta-thalassemia Major
- +2 more
- DFP (ferriprox) and deferasirox (ICL 670)
- DFP, DFO
-
Cairo, EgyptPediatric Hematology clinic, Ain Shams University
Feb 3, 2012
Thalassemia, Iron Overload, Transfusion Related Complications Trial in Bandar abbas (osveral, Desferal)
Completed
- Thalassemia
- +2 more
- osveral
- Desferal
-
Bandar abbas, Hormozgan, Iran, Islamic Republic ofHormozgan University of Medical Sciences (HUMS)
Jun 13, 2011
Iron Overload Trial in Philadelphia (deferiprone)
Approved for marketing
- Iron Overload
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Feb 8, 2012
Thalassemia Trial in New York (Deferoxamine, Deferasirox)
Unknown status
- Thalassemia
-
New York, New YorkWeill Cornell Medical Center
Nov 4, 2010
Iron Overload, Thalassemia Trial in New York (Combination Iron Chelation Therapy)
Completed
- Iron Overload
- Thalassemia
- Combination Iron Chelation Therapy
-
New York, New YorkCornell University Medical College
Jan 12, 2010